Cargando…
Trial of Early Antiviral Therapies during Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19: a summary of the protocol and analysis plan for a decentralized randomized controlled trial
BACKGROUND: Coronavirus disease 2019 (COVID-19) has a heterogeneous outcome in individuals from remaining asymptomatic to death. In a majority of cases, mild symptoms are present that do not require hospitalization and can be successfully treated in the outpatient setting, though symptoms may persis...
Autores principales: | Kaizer, Alexander M., Wild, Jessica, Lindsell, Christopher J., Rice, Todd W., Self, Wesley H., Brown, Samuel, Thompson, B. Taylor, Hart, Kimberly W., Smith, Clay, Pulia, Michael S., Shapiro, Nathan I., Ginde, Adit A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990452/ https://www.ncbi.nlm.nih.gov/pubmed/35395957 http://dx.doi.org/10.1186/s13063-022-06213-z |
Ejemplares similares
-
Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial
por: Kaizer, Alexander M., et al.
Publicado: (2023) -
Exposures in adult outpatients with COVID‐19 infection during early community transmission, Tennessee
por: Tenforde, Mark W., et al.
Publicado: (2020) -
Vitamin D Deficiency and Long-Term Cognitive Impairment Among Older Adult Emergency Department Patients
por: Evans, Christopher S., et al.
Publicado: (2019) -
A multicenter cluster randomized, stepped wedge implementation trial for targeted normoxia in critically ill trauma patients: study protocol and statistical analysis plan for the Strategy to Avoid Excessive Oxygen (SAVE-O2) trial
por: Dylla, Layne, et al.
Publicado: (2021) -
Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients
por: Zampieri, Fernando G., et al.
Publicado: (2021)